Cite
HARVARD Citation
Smyth, T. et al. (n.d.). Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models. European journal of cancer. pp. S44-S45. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smyth, T. et al. (n.d.). Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models. European journal of cancer. pp. S44-S45. [Online].